BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 10338811)

  • 1. Suture prices unlikely to drop further.
    Hosp Mater Manage; 1998 Dec; 23(12):1, 14-5. PubMed ID: 10338811
    [No Abstract]   [Full Text] [Related]  

  • 2. Suture price ships pass in the night.
    Hosp Mater Manage; 1995 Sep; 20(9):1, 10-1. PubMed ID: 10145124
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflation frustration. Higher prices for raw materials have begun to hit the cost of health products, and GPOs are feeling the pressure.
    Rhea S
    Mod Healthc; 2008 Sep; 38(35):S1-5. PubMed ID: 18792596
    [No Abstract]   [Full Text] [Related]  

  • 4. Pacemaker prices decline, but gently.
    Hosp Mater Manage; 1998 Jul; 23(7):1, 19-21. PubMed ID: 10183018
    [No Abstract]   [Full Text] [Related]  

  • 5. AmeriNet posts inflationary indices.
    Hosp Mater Manage; 1998 Dec; 23(12):16. PubMed ID: 10338815
    [No Abstract]   [Full Text] [Related]  

  • 6. Price survey. Paper bargains about to end.
    Hosp Mater Manage; 2002 Sep; 27(9):1, 12-3. PubMed ID: 12242872
    [No Abstract]   [Full Text] [Related]  

  • 7. Saving on sutures: a new perspective on one of the oldest surgical products.
    Berkey TB
    Hosp Mater Manage; 1996 Sep; 21(9):16-7. PubMed ID: 10160165
    [No Abstract]   [Full Text] [Related]  

  • 8. Premier rolls out latest pacts; discounts are leaner this time.
    DeJohn P
    Hosp Mater Manage; 1997 Feb; 22(2):1, 9, 13. PubMed ID: 10164915
    [No Abstract]   [Full Text] [Related]  

  • 9. Welcome drop seen in stent prices.
    Hosp Mater Manage; 2006 Jul; 31(7):1, 5-6. PubMed ID: 16871664
    [No Abstract]   [Full Text] [Related]  

  • 10. Suture price prospects vary by supplier.
    Hosp Mater Manage; 1997 Dec; 22(12):1, 14-6. PubMed ID: 10179098
    [No Abstract]   [Full Text] [Related]  

  • 11. GPOs say higher prices on the way in 2009.
    Hosp Mater Manage; 2008 Dec; 33(12):1-4. PubMed ID: 19156996
    [No Abstract]   [Full Text] [Related]  

  • 12. Group hysteria! Defining GPOs in the 1990s.
    Appel GL
    Mater Manag Health Care; 1996 Jan; 5(1):16, 18, 20. PubMed ID: 10156368
    [No Abstract]   [Full Text] [Related]  

  • 13. Price survey. Suture prices headed down.
    Hosp Mater Manage; 2001 Jan; 26(1):1, 14. PubMed ID: 11965644
    [No Abstract]   [Full Text] [Related]  

  • 14. Hip implant prices on way down.
    Hosp Mater Manage; 1995 Oct; 20(10):1, 12-3. PubMed ID: 10151991
    [No Abstract]   [Full Text] [Related]  

  • 15. I.V. prices may creep upward in 1999.
    Hosp Mater Manage; 1999 Jan; 24(1):1, 13-5. PubMed ID: 10339215
    [No Abstract]   [Full Text] [Related]  

  • 16. Using data for supply cost reduction. Comparatively speaking.
    Neil R
    Mater Manag Health Care; 2005 Jul; 14(7):18-22. PubMed ID: 16146164
    [No Abstract]   [Full Text] [Related]  

  • 17. Most hospital supply prices headed upward in 1998.
    Hosp Mater Manage; 1998 Jan; 23(1):2-3. PubMed ID: 10176481
    [No Abstract]   [Full Text] [Related]  

  • 18. HSCA price forecast. No surprise: prices of most items headed up.
    Hosp Mater Manage; 2001 Mar; 26(3):14-5. PubMed ID: 12018186
    [No Abstract]   [Full Text] [Related]  

  • 19. An empirical analysis of aftermarket transactions by hospitals.
    Litan RE; Singer HJ; Birkenbach A
    J Contemp Health Law Policy; 2011; 28(1):23-38. PubMed ID: 22292319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital supply and pharmaceutical costs are tied to competition in marketplace.
    Appel GL
    Hosp Mater Manage; 1995 Dec; 20(12):8-9. PubMed ID: 10152660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.